Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Core One Labs Inc. C.COOL

Alternate Symbol(s):  CLABF

Core One Labs Inc. is a Canada-based life sciences biotechnology research and development company. The Company is focused on bringing psychedelic medicines to market through the development and production of psychedelic compounds, the advancement of psychedelic assisted treatments, and the integration of delivery systems technology. The Company, through its wholly owned subsidiary, Vocan Biotechnologies Inc., has developed and filed for patent protection of a proprietary psilocybin production system using engineered bacteria. It is also the holder of four provisional patents for the development of psychedelic-based pharmaceutical formulations targeting neurological and mental health disorders, under its subsidiary Akome Biotech Ltd., and three provisional patents under its other subsidiary, Awakened Biosciences Inc., for additional synthetic technologies for psilocybin and psilocin production methods. It also holds an interest in four medical clinics.


CSE:COOL - Post by User

Bullboard Posts
Comment by cloreenbaconskinon Dec 01, 2016 8:42am
69 Views
Post# 25539004

RE:sound familiar

RE:sound familiarAnd also familiar...

AXIM has 0 revenue...51 million shares oustanding....but yet valued at $434 million US market cap....

LDS is extremely undervalued.  Peer comparisons are rational and relevant.  Whether the stock price is rational or not is irrelevant.  If AXIM is being valued at $434 million based on potential, then LDS should be given that same treatment. 



julia7777777777 wrote: AXIM Biotechnologies Inc. has made a name for itself by creating unique delivery systems for cannabinoids


The advancements that Dr. Sanderson has achieved will allow LDS to significantly differentiate the CannaStrips technology from any other delivery method currently available for any product worldwide." The company intends to incorporate these new innovations into the current product line in the first quarter of 2017.


Major diffference    axim   20cents to     8.44 as of yesterday in 6 weeks

lds    80 to roughly 80 cents in 6 weeks


conclusion...the latter is extremely undervalued in my opinion....




Bullboard Posts